Reader Comments

Year : 2021 | Volume:  6 | Issue Number:  1


Evidence of superiority of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors or angiotensin ii receptor blockers in the heart failure with reduced ejection fraction patient's journey

Gori Mauro, D'Elia Emilia, Senni Michele

Add Your Comments
No one has added comments on this article. Click here to add your remarks


Back To Article